Breast Cancer Diagnostic Testing Device Pipeline Assessment Report 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Breast Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Breast Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020”. Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample.

Scope

• Extensive coverage of the Breast Cancer Diagnostic Tests under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

(Read more…)

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Breast Cancer Overview

3 Products under Development

3.1 Breast Cancer – Pipeline Products by Stage of Development

3.2 Breast Cancer – Pipeline Products by Territory

3.3 Breast Cancer – Pipeline Products by Regulatory Path

3.4 Breast Cancer – Pipeline Products by Estimated Approval Date

3.5 Breast Cancer – Ongoing Clinical Trials

4 Breast Cancer – Pipeline Products under Development by Companies

4.1 Breast Cancer Companies – Pipeline Products by Stage of Development

4.2 Breast Cancer – Pipeline Products by Stage of Development

5 Breast Cancer Companies and Product Overview

6 Breast Cancer – Recent Developments

7 Appendix

Companies Mentioned

• A&G Pharmaceutical Inc
• Abviva Inc (Inactive)
• Accelerated Medical Diagnostics LLC
• Acobiom
• Affichem SA
• AIT Austrian Institute of Technology GmbH
• Albert Ludwigs University of Freiburg
• Alere Inc
• Allarity Therapeutics A/S
• Almac Diagnostic Services Ltd
• Amarantus Bioscience Holdings Inc
• AngioGenex Inc
• Anixa Diagnostics Corporation
• Armune BioScience Inc
• Arno Therapeutics Inc
• Assurance Biosciences, Inc. (Inactive)
• Atossa Therapeutics Inc
• Aurelium BioPharma Inc.
• Autoimmune Technologies LLC
• Avant Diagnostics Inc
• Ayanda Biosystems SA (Inactive)
• BARD1 Life Sciences Ltd
• Baylor College of Medicine
• BCAL Diagnostics Pty Limited
• Becton Dickinson and Co
• Biocrates Life Sciences AG
• BioDesign Institute at Arizona State University
• Biodesix Inc
• BioGenex Laboratories Inc
• Biolidics Ltd
• BioMarCare Technologies Ltd
• BioMark Diagnostics Inc
• BioMarker Strategies LLC
• bioMerieux SA
• Biomoda Inc
• Biosceptre International Ltd
• BioSystems International
• Caprion Biosciences Inc
• Caris Life Sciences Inc
• Celcuity Inc
• Cellanyx Diagnostics, Inc.
• CellXplore, Inc.
• Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco
• Cepheid Inc
• Ceres Nanosciences Inc
• Cernostics Inc
• China Sky One Medical Inc
• Chronix Biomedical Inc
• City of Hope
• Clarient Inc
• Cleveland Diagnostics Inc.
• CompanDX Ltd
• Courtagen Life Sciences Inc
• Daan Gene Co Ltd
• Dana-Farber Cancer Institute Inc
• Dartmouth College
• Dublin City University
• Entopsis LLC
• Eurobio Scientific SA
• Exact Sciences Corp
• Exosome Diagnostics Inc
• Exosomics Siena SpA
• Fahy Gurteen UK Ltd
• Fina Biotech SL
• Fluxion Biosciences Inc
• Fournira Optime Diagnostics
• French National Institute of Health and Medical Research
• Genome Diagnostics Pvt Ltd
• GenomicTree Co Ltd
• Genoptix Inc
• George Washington University
• German Cancer Research Center
• Ghent University
• GlyCa BioSciences Inc
• GlycoZym USA Inc
• Guardant Health Inc
• H. Lee Moffitt Cancer Center & Research Institute Inc
• Hai Kang Life Corp Ltd
• Health Discovery Corp
• HealthTell Inc
• Hebrew University of Jerusalem
• Heragen Inc
• Hitachi Chemical Diagnostics Inc
• Houston Methodist Hospital
• Ikonisys Inc
• Immunovia AB
• Inanovate Inc
• Insight Genetics Inc
• Inspirata Inc
• Institute of Cancer Research
• Institute of Molecular and Translational Medicine
• IPDx Immunoprofiling Diagnostics GmbH
• IRIS International Inc
• Johns Hopkins University
• Jonakee Cancer Research, Inc.
• Kalgene Pharmaceuticals Inc
• Leica Biosystems Nussloch GmbH
• Liv Diagnostics AB
• Louisville Bioscience Inc (Inactive)
• MabCure Inc
• Matrix-Bio Inc
• MDNA Life Sciences Inc
• MDxHealth SA
• MEDITE Cancer Diagnostics Inc
• MedMira Inc
• MedPacto Inc
• Metabolomic Technologies Inc
• MetaStat Inc
• Milagen Inc
• Morphotek Inc
• MW Diagnostics Ltd
• Nanostics Inc
• NanoString Technologies Inc
• New York University
• Newcastle University
• Nonagen Bioscience Corp
• Novel Bio-spectrum Technologies Inc (Inactive)
• Nuclea Biotechnologies Inc. (Inactive)
• Nuvera Biosciences Inc
• Olink Proteomics AB
• Olympia Diagnostics Inc
• Oncimmune (USA) LLC
• OncoCyte Corp
• Onconome, Inc. (Inactive)
• OncoStem Diagnostics Pvt. Ltd
• OncoVista Innovative Therapies Inc
• Oregon Health & Science University
• OSLER Diagnostics Ltd
• OTraces Inc
• Peri Rx Inc
• Power3 Medical Products, Inc.
• Precision Biologics Inc
• Prelude Corp
• PreMD Inc (Inactive)
• Princeton University
• Proplex Technologies Llc
• Protagen AG
• Proteome Sciences Plc
• Proteomika (Inactive)
• Purdue University
• Rna Diagnostics Inc
• Roche Diagnostics Corp
• Roche Diagnostics International Ltd
• Rosetta Genomics Ltd
• RWTH Aachen University
• Savicell Diagnostic Ltd.
• Selventa Inc
• Sengenics Corp Pte Ltd
• Siemens Healthineers AG
• SomaLogic Inc
• Soricimed Biopharma Inc
• Syantra Inc
• Target Discovery Inc
• Taxor Diagnostics, LLC
• TechnoGenesys, Inc.
• The University of Nottingham
• Treos Bio Inc
• Trinity College Dublin
• Universal Diagnostics SL
• University of Alberta
• University of Bergen
• University of Bonn
• University of California San Diego
• University of Colorado
• University of Hong Kong
• University of Kansas
• University of Lyon
• University of Minnesota
• University of Missouri
• University of Nebraska
• University of Oxford
• University of Pittsburgh
• University of South Carolina
• University of South Florida
• University of Toledo
• University of Turku
• University of Wisconsin Madison
• US Biomarkers Inc
• Vala Sciences Inc
• Vermillion Inc
• Viomics Inc.
• Vitruvian Biomedical Inc
• VolitionRX Ltd
• Washington University in St Louis
• XEPTAGEN SpA
• Zetiq Technologies Ltd

For more information about this report visit https://www.researchandmarkets.com/r/91bptx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900